Articles

Announcing the SPARCLE consortium

We're excited to announce our involvement in the €11.5 million SPARCLE Consortium, a high-impact neurotech consortium comprising some of Europe’s leading neurotech companies, research organisations, and universities.

Cancer sucks

A piece by our founder Elise Jenkins.

Coherence — Creating a $100B Industry at the Frontier of Neuroscience and Oncology

Learn more about the electrical language of the body.

Our Co-Founder in Conversation with XEIA Ventures

Our Cofounder and CEO, Ben Woodington, sits down with Brom Rector of XEIA ventures to discuss the future of neurotechnology and the huge opportunity in helping patients with brain cancer

Our Co-founder featured on the Humanware podcast

Our co-founder and CEO Dr Ben Woodington, sits down with Méline Liu, host of the Humanware series. Join them for a conversation about BCI, neurotech and Coherence's approach to treating disease using implantable electronic devices.

The implant will see you now

Real-time neural diagnostics and data-enabled neurotechnologies are here. Welcome to the world of theranostic neurotechnology.

No results found!

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.